Clinical Trial Update: REFLOW Study, Investigating the Efficacy of the LEGFLOW DCB in TASC C&D Fempop Lesions [Phase 3]

View source ↗

Summary

Phase 3 trial update for the LEGFLOW drug-coated balloon in complex femoropopliteal lesions (TASC C&D) within peripheral arterial disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• LEGFLOW

Snippet

Sponsor: Flanders Medical Research Program | Conditions: Peripheral Arterial Disease | Phase 3 | Status: UNKNOWN